{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T05:32:14Z","timestamp":1794461534575,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173322"],"award-info":[{"award-number":["82173322"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072998"],"award-info":[{"award-number":["82072998"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Salivary gland tumors (SGTs) include a large group of rare neoplasms in the head and neck region, and the heterogeneous and overlapping features among the subtypes frequently make diagnostic difficulties. There is an urgent need to understand the cellular mechanisms underlying the heterogeneity and overlap among the subtypes, and explore the subtype-specific diagnostic biomarkers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The tumor tissue and the adjacent normal tissue from the 6 most common types of SGTs were processed for organoid culture which only maintained tumor epithelial cells. Organoids were histologically evaluated based on phenotype markers, followed by transcriptional profiling using RNA-sequencing. The transcriptomic similarities and differences among the subtypes were analyzed by subtype consensus clustering and hierarchical clustering. Furthermore, by comparative transcriptional analysis for these 6 types of SGTs and the matched organoids, the potential diagnostic biomarkers from tumor epithelium were identified, in which two selected biomarkers were evaluated by qPCR and confirmed by immunohistochemistry staining using a tissue microarray.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We generated a biobank of patient-derived organoids (PDOs) with 6 subtypes of SGTs, including 21 benign and 24 malignant SGTs. The PDOs recapitulated the morphological and transcriptional characteristics of the parental tumors. The overlap in the cell types and the heterogenous growth patterns were observed in the different subtypes of organoids. Comparing the bulk tissues, the cluster analysis of the PDOs remarkably revealed the epithelial characteristics, and visualized the intrinsic relationship among these subtypes. Finally, the exclusive biomarkers for the 6 most common types of SGTs were uncovered by comparative analysis, and PTP4A1 was demonstrated as a useful diagnostic biomarker for mucoepidermoid carcinoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We established the first organoid biobank with multiple subtypes of SGTs. PDOs of SGTs recapitulate the morphological and transcriptional characteristics of the original tumors, which uncovers subtype-specific biomarkers and reveals the molecular distance among the subtype of SGTs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13046-022-02561-5","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T02:02:36Z","timestamp":1671242556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["An organoid library of salivary gland tumors reveals subtype-specific characteristics and biomarkers"],"prefix":"10.1186","volume":"41","author":[{"given":"Bo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixuan","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolian","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabing","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxiang","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,17]]},"reference":[{"issue":"5","key":"2561_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1034\/j.1601-0825.2002.02870.x","volume":"8","author":"PM Speight","year":"2002","unstructured":"Speight PM, Barrett AW. Salivary gland tumours. Oral Dis. 2002;8(5):229\u201340.","journal-title":"Oral Dis"},{"issue":"1","key":"2561_CR2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12885-019-5564-x","volume":"19","author":"JY Fu","year":"2019","unstructured":"Fu JY, et al. Salivary gland carcinoma in Shanghai (2003-2012): an epidemiological study of incidence, site and pathology. BMC Cancer. 2019;19(1):350.","journal-title":"BMC Cancer"},{"key":"2561_CR3","first-page":"1","volume-title":"Distribution and frequency of salivary gland Tumours: an international multicenter study","author":"I Alsanie","year":"2022","unstructured":"Alsanie I, et al. Distribution and frequency of salivary gland Tumours: an international multicenter study, vol. 27: Head Neck Pathol; 2022. p. 1\u20132."},{"issue":"1","key":"2561_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12105-017-0795-0","volume":"11","author":"RR Seethala","year":"2017","unstructured":"Seethala RR, Stenman G. Update from the 4th edition of the World Health Organization classification of head and neck Tumours: tumors of the salivary gland. Head Neck Pathol. 2017;11(1):55\u201367.","journal-title":"Head Neck Pathol"},{"issue":"15","key":"2561_CR5","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.3390\/cancers13153910","volume":"13","author":"J Iyer","year":"2021","unstructured":"Iyer J, et al. An overview on the histogenesis and morphogenesis of salivary gland neoplasms and evolving diagnostic approaches. Cancers. 2021;13(15):3910.","journal-title":"Cancers"},{"issue":"5","key":"2561_CR6","doi-asserted-by":"publisher","first-page":"e23211","DOI":"10.1002\/dvg.23211","volume":"56","author":"E Emmerson","year":"2018","unstructured":"Emmerson E, Knox SM. Salivary gland stem cells: a review of development, regeneration and cancer. Genesis. 2018;56(5):e23211.","journal-title":"Genesis"},{"issue":"12","key":"2561_CR7","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1158\/1078-0432.CCR-19-3758","volume":"26","author":"M Linxweiler","year":"2020","unstructured":"Linxweiler M, et al. The immune microenvironment and Neoantigen landscape of aggressive salivary gland carcinomas differ by subtype. Clin Cancer Res. 2020;26(12):2859\u201370.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"2561_CR8","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1158\/1078-0432.CCR-17-3871","volume":"24","author":"SB Keysar","year":"2018","unstructured":"Keysar SB, et al. Salivary gland Cancer patient-derived xenografts enable characterization of Cancer stem cells and new gene events associated with tumor progression. Clin Cancer Res. 2018;24(12):2935\u201343.","journal-title":"Clin Cancer Res"},{"issue":"18","key":"2561_CR9","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1158\/1078-0432.CCR-16-0637","volume":"22","author":"MG Dalin","year":"2016","unstructured":"Dalin MG, et al. Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast Cancer. Clin Cancer Res. 2016;22(18):4623\u201333.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2561_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ijc.33315","volume":"148","author":"K Takada","year":"2021","unstructured":"Takada K, et al. Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method. Int J Cancer. 2021;148(1):193\u2013202.","journal-title":"Int J Cancer"},{"issue":"3","key":"2561_CR11","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/1078-0432.CCR-20-1192","volume":"27","author":"R Ferrarotto","year":"2021","unstructured":"Ferrarotto R, et al. Proteogenomic analysis of salivary adenoid cystic carcinomas defines molecular subtypes and identifies therapeutic targets. Clin Cancer Res. 2021;27(3):852\u201364.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2561_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","volume":"18","author":"J Drost","year":"2018","unstructured":"Drost J, Clevers H. Organoids in cancer research. Nat Rev Cancer. 2018;18(7):407\u201318.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2561_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-11867-6","volume":"10","author":"M Kim","year":"2019","unstructured":"Kim M, et al. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening. Nat Commun. 2019;10(1):1\u201315.","journal-title":"Nat Commun"},{"issue":"12","key":"2561_CR14","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier L, et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med. 2017;23(12):1424\u201335.","journal-title":"Nat Med"},{"issue":"5","key":"2561_CR15","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1158\/1078-0432.CCR-19-1376","volume":"26","author":"R Shi","year":"2020","unstructured":"Shi R, et al. Organoid Cultures as Preclinical Models of Non\u2013Small Cell Lung CancerNon\u2013Small Cell Lung Cancer Organoids. Clin Cancer Res. 2020;26(5):1162\u201374.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2561_CR16","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1038\/s41467-021-22117-z","volume":"12","author":"G Inak","year":"2021","unstructured":"Inak G, et al. Defective metabolic programming impairs early neuronal morphogenesis in neural cultures and an organoid model of Leigh syndrome. Nat Commun. 2021;12(1):1929.","journal-title":"Nat Commun"},{"key":"2561_CR17","doi-asserted-by":"publisher","first-page":"14262","DOI":"10.1038\/ncomms14262","volume":"8","author":"M Schutte","year":"2017","unstructured":"Schutte M, et al. Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors. Nat Commun. 2017;8:14262.","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"2561_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","volume":"172","author":"N Sachs","year":"2018","unstructured":"Sachs N, et al. A living biobank of breast Cancer organoids captures disease heterogeneity. Cell. 2018;172(1\u20132):373\u2013386 e10.","journal-title":"Cell"},{"issue":"1","key":"2561_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jcmgh.2018.09.003","volume":"7","author":"T Kijima","year":"2019","unstructured":"Kijima T, et al. Three-dimensional organoids reveal therapy resistance of esophageal and oropharyngeal squamous cell carcinoma cells. Cell Mol Gastroenterol Hepatol. 2019;7(1):73\u201391.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"10","key":"2561_CR20","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1038\/s41596-020-0379-4","volume":"15","author":"E Driehuis","year":"2020","unstructured":"Driehuis E, Kretzschmar K, Clevers H. Establishment of patient-derived cancer organoids for drug-screening applications. Nat Protoc. 2020;15(10):3380\u2013409.","journal-title":"Nat Protoc"},{"issue":"7","key":"2561_CR21","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/2159-8290.CD-18-1522","volume":"9","author":"E Driehuis","year":"2019","unstructured":"Driehuis E, et al. Oral mucosal organoids as a potential platform for personalized Cancer therapy. Cancer discovery. 2019;9(7):852\u201371.","journal-title":"Cancer discovery"},{"key":"2561_CR22","doi-asserted-by":"crossref","unstructured":"Yoshimoto S, et al. Inhibition of Alk signaling promotes the induction of human salivary-gland-derived organoids. Dis Model Mech. 2020;13(9).","DOI":"10.1242\/dmm.045054"},{"issue":"22","key":"2561_CR23","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1038\/s41388-019-0722-9","volume":"38","author":"G Zang","year":"2019","unstructured":"Zang G, et al. PKCzeta facilitates lymphatic metastatic spread of prostate cancer cells in a mice xenograft model. Oncogene. 2019;38(22):4215\u201331.","journal-title":"Oncogene"},{"issue":"1","key":"2561_CR24","first-page":"3221","volume":"15","author":"L Van Der Maaten","year":"2014","unstructured":"Van Der Maaten L. Accelerating t-SNE using tree-based algorithms. The J of Machine Learn Res. 2014;15(1):3221\u201345.","journal-title":"The J of Machine Learn Res"},{"issue":"4","key":"2561_CR25","doi-asserted-by":"publisher","first-page":"e0152792","DOI":"10.1371\/journal.pone.0152792","volume":"11","author":"T Xu","year":"2016","unstructured":"Xu T, et al. Identifying Cancer subtypes from miRNA-TF-mRNA regulatory networks and expression data. PLoS One. 2016;11(4):e0152792.","journal-title":"PLoS One"},{"issue":"1","key":"2561_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/cpbi.96","volume":"69","author":"G Yu","year":"2020","unstructured":"Yu G. Using ggtree to visualize data on tree-like structures. Curr Protoc Bioinformatics. 2020;69(1):e96.","journal-title":"Curr Protoc Bioinformatics"},{"key":"2561_CR27","doi-asserted-by":"publisher","first-page":"e18489","DOI":"10.7554\/eLife.18489","volume":"5","author":"CS Verissimo","year":"2016","unstructured":"Verissimo CS, et al. Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening. elife. 2016;5:e18489.","journal-title":"elife"},{"issue":"7","key":"2561_CR28","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","volume":"18","author":"J Drost","year":"2018","unstructured":"Drost J, Clevers H. Organoids in cancer research. Nat Rev Cancer. 2018;18(7):407\u201318.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2561_CR29","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3390\/jcm11071808","volume":"11","author":"SY Choi","year":"2022","unstructured":"Choi SY, et al. Comparative longitudinal analysis of malignant transformation in pleomorphic adenoma and recurrent pleomorphic adenoma. J Clin Med. 2022;11(7):1808.","journal-title":"J Clin Med"},{"issue":"2","key":"2561_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.devcel.2015.02.013","volume":"33","author":"MH Aure","year":"2015","unstructured":"Aure MH, Konieczny SF, Ovitt CE. Salivary gland homeostasis is maintained through acinar cell self-duplication. Dev Cell. 2015;33(2):231\u20137.","journal-title":"Dev Cell"},{"issue":"7","key":"2561_CR31","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/01.pas.0000159103.95360.e8","volume":"29","author":"A Handra-Luca","year":"2005","unstructured":"Handra-Luca A, et al. MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland mucoepidermoid carcinoma: diagnostic and prognostic implications. Am J Surg Pathol. 2005;29(7):881\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2561_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/PAS.0b013e318184b36d","volume":"33","author":"I Weinreb","year":"2009","unstructured":"Weinreb I, et al. Oncocytic mucoepidermoid carcinoma: clinicopathologic description in a series of 12 cases. Am J Surg Pathol. 2009;33(3):409\u201316.","journal-title":"Am J Surg Pathol"},{"issue":"13","key":"2561_CR33","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.3390\/ijms22136771","volume":"22","author":"MT Meyer","year":"2021","unstructured":"Meyer MT, et al. 2021 update on diagnostic markers and translocation in salivary gland tumors. Int J Mol Sci. 2021;22(13):6771.","journal-title":"Int J Mol Sci"},{"key":"2561_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-pathmechdis-012419-032611","volume":"15","author":"F Schutgens","year":"2020","unstructured":"Schutgens F, Clevers H. Human organoids: tools for understanding biology and treating diseases. Annual Rev of Pathol: Mecha of Dis. 2020;15:211\u201334.","journal-title":"Annual Rev of Pathol: Mecha of Dis"},{"issue":"1","key":"2561_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/stem.2455","volume":"35","author":"I Lombaert","year":"2017","unstructured":"Lombaert I, et al. Concise review: salivary gland regeneration: therapeutic approaches from stem cells to tissue organoids. Stem Cells. 2017;35(1):97\u2013105.","journal-title":"Stem Cells"},{"key":"2561_CR36","doi-asserted-by":"publisher","first-page":"106186","DOI":"10.1016\/j.oraloncology.2022.106186","volume":"135","author":"G Lassche","year":"2022","unstructured":"Lassche G, et al. Development and characterization of patient-derived salivary gland cancer organoid cultures. Oral Oncol. 2022;135:106186.","journal-title":"Oral Oncol"},{"issue":"1","key":"2561_CR37","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1038\/s41467-022-30934-z","volume":"13","author":"YJ Yoon","year":"2022","unstructured":"Yoon YJ, et al. Salivary gland organoid culture maintains distinct glandular properties of murine and human major salivary glands. Nat Commun. 2022;13(1):3291.","journal-title":"Nat Commun"},{"issue":"1","key":"2561_CR38","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1038\/modpathol.2016.190","volume":"30","author":"RR Seethala","year":"2017","unstructured":"Seethala RR. Basaloid\/blue salivary gland tumors. Mod Pathol. 2017;30(1):S84\u201395.","journal-title":"Mod Pathol"},{"issue":"2","key":"2561_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.stem.2016.05.012","volume":"19","author":"H Mou","year":"2016","unstructured":"Mou H, et al. Dual SMAD signaling inhibition enables long-term expansion of diverse epithelial basal cells. Cell Stem Cell. 2016;19(2):217\u201331.","journal-title":"Cell Stem Cell"},{"issue":"7822","key":"2561_CR40","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41586-020-2632-y","volume":"584","author":"A Centonze","year":"2020","unstructured":"Centonze A, et al. Heterotypic cell\u2013cell communication regulates glandular stem cell multipotency. Nature. 2020;584(7822):608\u201313.","journal-title":"Nature"},{"issue":"9","key":"2561_CR41","doi-asserted-by":"publisher","first-page":"e20201916","DOI":"10.1084\/jem.20201916","volume":"218","author":"A-H Gy\u00f6rfi","year":"2021","unstructured":"Gy\u00f6rfi A-H, et al. Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation. J Exp Med. 2021;218(9):e20201916.","journal-title":"J Exp Med"},{"issue":"2","key":"2561_CR42","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/carcin\/bgaa133","volume":"42","author":"R Chen","year":"2021","unstructured":"Chen R, et al. SNAIL regulates gastric carcinogenesis through CCN3 and NEFL. Carcinogenesis. 2021;42(2):190\u2013201.","journal-title":"Carcinogenesis"},{"issue":"5","key":"2561_CR43","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3892\/ijo.2013.2094","volume":"43","author":"S Kang","year":"2013","unstructured":"Kang S, et al. Stage-specific methylome screen identifies that NEFL is downregulated by promoter hypermethylation in breast cancer. Int J Oncol. 2013;43(5):1659\u201365.","journal-title":"Int J Oncol"},{"issue":"21","key":"2561_CR44","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1111\/febs.14503","volume":"285","author":"S Hardy","year":"2018","unstructured":"Hardy S, et al. Physiological and oncogenic roles of the PRL phosphatases. FEBS J. 2018;285(21):3886\u2013908.","journal-title":"FEBS J"},{"issue":"6589","key":"2561_CR45","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/382360a0","volume":"382","author":"CA Loomis","year":"1996","unstructured":"Loomis CA, et al. The mouse Engrailed-1 gene and ventral limb patterning. Nature. 1996;382(6589):360\u20133.","journal-title":"Nature"},{"issue":"10","key":"2561_CR46","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/sj.bjc.6605045","volume":"100","author":"R Mayor","year":"2009","unstructured":"Mayor R, et al. Long-range epigenetic silencing at 2q14. 2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease. Br J Cancer. 2009;100(10):1534\u20139.","journal-title":"Br J Cancer"},{"issue":"1","key":"2561_CR47","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1158\/1055-9965.EPI-10-0719","volume":"20","author":"J Devaney","year":"2011","unstructured":"Devaney J, et al. Epigenetic deregulation across chromosome 2q14. 2 differentiates Normal from prostate Cancer and provides a regional panel of novel DNA methylation Cancer BiomarkersEpigenetic deregulation across 2q14. 2 in prostate Cancer. Cancer Epidemiol Biomark Prev. 2011;20(1):148\u201359.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"2","key":"2561_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/pin.13050","volume":"71","author":"S Baba","year":"2021","unstructured":"Baba S, et al. Homeobox transcription factor engrailed homeobox 1 is a possible diagnostic marker for adenoid cystic carcinoma and polymorphous adenocarcinoma. Pathol Int. 2021;71(2):113\u201323.","journal-title":"Pathol Int"},{"issue":"1","key":"2561_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-82169-5","volume":"11","author":"JW Robinson","year":"2021","unstructured":"Robinson JW, et al. Transcriptome-wide Mendelian randomization study prioritising novel tissue-dependent genes for glioma susceptibility. Sci Rep. 2021;11(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"6","key":"2561_CR50","first-page":"2476","volume":"23","author":"X Huo","year":"2019","unstructured":"Huo X, et al. HOXB7 promotes proliferation and metastasis of glioma by regulating the Wnt\/beta-catenin pathway. Eur Rev Med Pharmacol Sci. 2019;23(6):2476\u201385.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"26","key":"2561_CR51","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1038\/s41388-018-0229-9","volume":"37","author":"S Monterisi","year":"2018","unstructured":"Monterisi S, et al. HOXB7 overexpression in lung cancer is a hallmark of acquired stem-like phenotype. Oncogene. 2018;37(26):3575\u201388.","journal-title":"Oncogene"},{"issue":"5","key":"2561_CR52","first-page":"515","volume":"9","author":"SA de Bessa Garcia","year":"2021","unstructured":"de Bessa Garcia SA, et al. HOXB7 overexpression leads triple-negative breast Cancer cells to a less aggressive phenotype. Biomed. 2021;9(5):515.","journal-title":"Biomed"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02561-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-022-02561-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02561-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T03:06:29Z","timestamp":1671246389000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-022-02561-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,17]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2561"],"URL":"https:\/\/doi.org\/10.1186\/s13046-022-02561-5","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,17]]},"assertion":[{"value":"30 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The human specimens involved in this study were reviewed and approved by the Ethics Committee of Stomatology Hospital, China Medical University. All the experiments were undertaken following the Ethic permission No. (2020\u201303), and the study methodologies conformed to the standards set by the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"350"}}